Cover Page
Cover Page | May 04, 2021 | Apr. 02, 2021 |
Cover [Abstract] | ||
Document Type | 8-K | |
Document Period End Date | May 4, 2021 | |
Entity Registrant Name | Supernus Pharmaceuticals, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Filer Name | 001-35518 | |
Entity Tax Identification Number | 20-2590184 | |
Entity Address, Address Line One | 9715 Key West Ave | |
Entity Address, City or Town | Rockville | |
Entity Address, State or Province | MD | |
Entity Address, Postal Zip Code | 20850 | |
City Area Code | 301 | |
Local Phone Number | 838-2500 | |
Title of 12(b) Security | Common Stock, $0.001 par value per share | |
Trading Symbol | SUPN | |
Security Exchange Name | NASDAQ | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Entity Emerging Growth Company | false | |
Amendment Flag | false | |
Entity Central Index Key | 0001356576 |